TY - JOUR AU - Hanahan, D. AU - Weinberg, R. A. PY - 2000 DA - 2000// TI - The hallmarks of cancer JO - Cell VL - 100 UR - https://doi.org/10.1016/S0092-8674(00)81683-9 DO - 10.1016/S0092-8674(00)81683-9 ID - Hanahan2000 ER - TY - JOUR AU - Mittal, D. AU - Gubin, M. M. AU - Schreiber, R. D. AU - Smyth, M. J. PY - 2014 DA - 2014// TI - New insights into cancer immunoediting and its three component phases–elimination, equilibrium and escape JO - Curr Opin Immunol VL - 27 UR - https://doi.org/10.1016/j.coi.2014.01.004 DO - 10.1016/j.coi.2014.01.004 ID - Mittal2014 ER - TY - JOUR AU - Kim, R. AU - Emi, M. AU - Tanabe, K. PY - 2007 DA - 2007// TI - Cancer immunoediting from immune surveillance to immune escape JO - Immunology VL - 121 UR - https://doi.org/10.1111/j.1365-2567.2007.02587.x DO - 10.1111/j.1365-2567.2007.02587.x ID - Kim2007 ER - TY - JOUR AU - Grivennikov, S. I. AU - Greten, F. R. AU - Karin, M. PY - 2010 DA - 2010// TI - Immunity, inflammation, and cancer JO - Cell VL - 140 UR - https://doi.org/10.1016/j.cell.2010.01.025 DO - 10.1016/j.cell.2010.01.025 ID - Grivennikov2010 ER - TY - JOUR AU - Horna, P. AU - Sotomayor, E. M. PY - 2007 DA - 2007// TI - Cellular and molecular mechanisms of tumor-induced T-cell tolerance JO - Curr Cancer Drug Targets VL - 7 UR - https://doi.org/10.2174/156800907780006940 DO - 10.2174/156800907780006940 ID - Horna2007 ER - TY - JOUR AU - Intlekofer, A. M. AU - Thompson, C. B. PY - 2013 DA - 2013// TI - At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy JO - J Leukoc Biol VL - 94 UR - https://doi.org/10.1189/jlb.1212621 DO - 10.1189/jlb.1212621 ID - Intlekofer2013 ER - TY - JOUR AU - Mytar, B. AU - Wołoszyn, M. AU - Szatanek, R. AU - Baj-Krzyworzeka, M. AU - Siedlar, M. AU - Ruggiero, I. PY - 2003 DA - 2003// TI - Tumor cell-induced deactivation of human monocytes JO - J Leukoc Biol VL - 74 UR - https://doi.org/10.1189/jlb.0403140 DO - 10.1189/jlb.0403140 ID - Mytar2003 ER - TY - JOUR AU - Chanmee, T. AU - Ontong, P. AU - Konno, K. AU - Itano, N. PY - 2014 DA - 2014// TI - Tumor-associated macrophages as major players in the tumor microenvironment JO - Cancers. VL - 6 UR - https://doi.org/10.3390/cancers6031670 DO - 10.3390/cancers6031670 ID - Chanmee2014 ER - TY - JOUR AU - Król, M. AU - Pawłowski, K. M. AU - Majchrzak, K. AU - Dolka, I. AU - Abramowicz, A. AU - Szyszko, K. PY - 2011 DA - 2011// TI - Density of tumor-associated macrophages (TAMs) and expression of their growth factor receptor MCSF-R and CD14 in canine mammary adenocarcinomas of various grade of malignancy and metastasis JO - Pol J Vet Sci VL - 14 UR - https://doi.org/10.2478/v10181-011-0001-3 DO - 10.2478/v10181-011-0001-3 ID - Król2011 ER - TY - JOUR AU - Mucha, J. AU - Majchrzak, K. AU - Taciak, B. AU - Hellmén, E. AU - Król, M. PY - 2014 DA - 2014// TI - MDSCs mediate angiogenesis and predispose canine mammary tumor cells for metastasis via IL-28/IL-28RA (IFN-λ) signaling JO - PLoS ONE VL - 9 UR - https://doi.org/10.1371/journal.pone.0103249 DO - 10.1371/journal.pone.0103249 ID - Mucha2014 ER - TY - JOUR AU - Delorme, E. PY - 1964 DA - 1964// TI - Treatment of primary fibrosarcoma in the rat with immune lymphocytes JO - Lancet VL - 284 UR - https://doi.org/10.1016/S0140-6736(64)90126-6 DO - 10.1016/S0140-6736(64)90126-6 ID - Delorme1964 ER - TY - JOUR AU - Paoloni, M. AU - Khanna, C. PY - 2008 DA - 2008// TI - Translation of new cancer treatments from pet dogs to humans JO - Nat Rev Cancer VL - 8 UR - https://doi.org/10.1038/nrc2273 DO - 10.1038/nrc2273 ID - Paoloni2008 ER - TY - JOUR AU - Schiffman, J. D. AU - Breen, M. PY - 2015 DA - 2015// TI - Comparative oncology: what dogs and other species can teach us about humans with cancer JO - Philos Trans R Soc B Biol Sci VL - 370 UR - https://doi.org/10.1098/rstb.2014.0231 DO - 10.1098/rstb.2014.0231 ID - Schiffman2015 ER - TY - JOUR AU - Mata, M. AU - Gottschalk, S. PY - 2016 DA - 2016// TI - Man’s best friend: utilizing naturally occurring tumors in dogs to improve chimeric antigen receptor T-cell therapy for human cancers JO - Mol Ther VL - 24 UR - https://doi.org/10.1038/mt.2016.173 DO - 10.1038/mt.2016.173 ID - Mata2016 ER - TY - STD TI - Stroud C, Dmitriev I, Kashentseva E, Bryan JN, Curiel DT, Rindt H, et al. A one health overview, facilitating advances in comparative medicine and translational research. Clin Transl Med. 2016;5. http://clintransmed.springeropen.com/articles/10.1186/s40169-016-0107-4. Accessed 30 Jun 2017. UR - http://clintransmed.springeropen.com/articles/10.1186/s40169-016-0107-4 ID - ref15 ER - TY - STD TI - Park JS, Withers SS, Modiano JF, Kent MS, Chen M, Luna JI, et al. Canine cancer immunotherapy studies: linking mouse and human. J Immunother Cancer. 2016; 4. http://jitc.biomedcentral.com/articles/10.1186/s40425-016-0200-7. Accessed 29 Jun 2017. UR - http://jitc.biomedcentral.com/articles/10.1186/s40425-016-0200-7 ID - ref16 ER - TY - JOUR AU - Khanna, C. AU - Lindblad-Toh, K. AU - Vail, D. AU - London, C. AU - Bergman, P. AU - Barber, L. PY - 2006 DA - 2006// TI - The dog as a cancer model JO - Nat Biotechnol VL - 24 UR - https://doi.org/10.1038/nbt0906-1065b DO - 10.1038/nbt0906-1065b ID - Khanna2006 ER - TY - JOUR AU - Bronson, R. T. PY - 1982 DA - 1982// TI - Variation in age at death of dogs of different sexes and breeds JO - Am J Vet Res VL - 43 ID - Bronson1982 ER - TY - JOUR AU - Anderson, K. L. AU - Modiano, J. F. PY - 2015 DA - 2015// TI - Progress in adaptive immunotherapy for cancer in companion animals: success on the path to a cure JO - Vet Sci VL - 2 UR - https://doi.org/10.3390/vetsci2040363 DO - 10.3390/vetsci2040363 ID - Anderson2015 ER - TY - JOUR AU - Nishiya, A. AU - Massoco, C. AU - Felizzola, C. AU - Perlmann, E. AU - Batschinski, K. AU - Tedardi, M. PY - 2016 DA - 2016// TI - Comparative aspects of canine melanoma JO - Vet Sci VL - 3 UR - https://doi.org/10.3390/vetsci3010007 DO - 10.3390/vetsci3010007 ID - Nishiya2016 ER - TY - JOUR AU - Lindblad-Toh, K. AU - Wade, C. M. AU - Mikkelsen, T. S. AU - Karlsson, E. K. AU - Jaffe, D. B. AU - Kamal, M. PY - 2005 DA - 2005// TI - Genome sequence, comparative analysis and haplotype structure of the domestic dog JO - Nature VL - 438 UR - https://doi.org/10.1038/nature04338 DO - 10.1038/nature04338 ID - Lindblad-Toh2005 ER - TY - JOUR AU - Muranski, P. AU - Restifo, N. P. PY - 2009 DA - 2009// TI - Adoptive immunotherapy of cancer using CD4(+) T cells JO - Curr Opin Immunol VL - 21 UR - https://doi.org/10.1016/j.coi.2009.02.004 DO - 10.1016/j.coi.2009.02.004 ID - Muranski2009 ER - TY - JOUR AU - Rosenberg, S. A. AU - Restifo, N. P. PY - 2015 DA - 2015// TI - Adoptive cell transfer as personalized immunotherapy for human cancer JO - Science VL - 348 UR - https://doi.org/10.1126/science.aaa4967 DO - 10.1126/science.aaa4967 ID - Rosenberg2015 ER - TY - JOUR AU - Rosenberg, S. A. AU - Restifo, N. P. AU - Yang, J. C. AU - Morgan, R. A. AU - Dudley, M. E. PY - 2008 DA - 2008// TI - Adoptive cell transfer: a clinical path to effective cancer immunotherapy JO - Nat Rev Cancer VL - 8 UR - https://doi.org/10.1038/nrc2355 DO - 10.1038/nrc2355 ID - Rosenberg2008 ER - TY - JOUR AU - Raval, R. R. AU - Sharabi, A. B. AU - Walker, A. J. AU - Drake, C. G. AU - Sharma, P. PY - 2014 DA - 2014// TI - Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer JO - J Immunother Cancer VL - 2 UR - https://doi.org/10.1186/2051-1426-2-14 DO - 10.1186/2051-1426-2-14 ID - Raval2014 ER - TY - JOUR AU - Mahmoud, S. M. A. AU - Paish, E. C. AU - Powe, D. G. AU - Macmillan, R. D. AU - Grainge, M. J. AU - Lee, A. H. S. PY - 2011 DA - 2011// TI - Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer JO - J Clin Oncol Off J Am Soc Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.30.5037 DO - 10.1200/JCO.2010.30.5037 ID - Mahmoud2011 ER - TY - STD TI - Wang K, Xu J, Zhang T, Xue D. Tumor-infiltrating lymphocytes in breast cancer predict the response to chemotherapy and survival outcome: a meta-analysis. Oncotarget. 2014. http://www.oncotarget.com/abstract/9988. Accessed 29 Jun 2017. UR - http://www.oncotarget.com/abstract/9988 ID - ref27 ER - TY - JOUR AU - Nguyen, N. AU - Bellile, E. AU - Thomas, D. AU - McHugh, J. AU - Rozek, L. AU - Virani, S. PY - 2016 DA - 2016// TI - Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma: tumor infiltrating lymphocytes JO - Head Neck VL - 38 UR - https://doi.org/10.1002/hed.24406 DO - 10.1002/hed.24406 ID - Nguyen2016 ER - TY - JOUR AU - Piras, F. AU - Colombari, R. AU - Minerba, L. AU - Murtas, D. AU - Floris, C. AU - Maxia, C. PY - 2005 DA - 2005// TI - The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase JO - Cancer VL - 104 UR - https://doi.org/10.1002/cncr.21283 DO - 10.1002/cncr.21283 ID - Piras2005 ER - TY - JOUR AU - Houdt, I. S. AU - Sluijter, B. J. R. AU - Moesbergen, L. M. AU - Vos, W. M. AU - Gruijl, T. D. AU - Molenkamp, B. G. PY - 2008 DA - 2008// TI - Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression JO - Int J Cancer VL - 123 UR - https://doi.org/10.1002/ijc.23543 DO - 10.1002/ijc.23543 ID - Houdt2008 ER - TY - JOUR AU - Sjödahl, G. AU - Lövgren, K. AU - Lauss, M. AU - Chebil, G. AU - Patschan, O. AU - Gudjonsson, S. PY - 2014 DA - 2014// TI - Infiltration of CD3+ and CD68+ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors JO - Urol Oncol VL - 32 UR - https://doi.org/10.1016/j.urolonc.2014.02.007 DO - 10.1016/j.urolonc.2014.02.007 ID - Sjödahl2014 ER - TY - JOUR AU - Hadrup, S. R. AU - Braendstrup, O. AU - Jacobsen, G. K. AU - Mortensen, S. AU - Pedersen, L. Ø. AU - Seremet, T. PY - 2006 DA - 2006// TI - Tumor infiltrating lymphocytes in seminoma lesions comprise clonally expanded cytotoxic T cells JO - Int J Cancer VL - 119 UR - https://doi.org/10.1002/ijc.21894 DO - 10.1002/ijc.21894 ID - Hadrup2006 ER - TY - JOUR AU - Fukunaga, A. AU - Miyamoto, M. AU - Cho, Y. AU - Murakami, S. AU - Kawarada, Y. AU - Oshikiri, T. PY - 2004 DA - 2004// TI - CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma JO - Pancreas VL - 28 UR - https://doi.org/10.1097/00006676-200401000-00023 DO - 10.1097/00006676-200401000-00023 ID - Fukunaga2004 ER - TY - JOUR AU - Piersma, S. J. AU - Jordanova, E. S. AU - Poelgeest, M. I. E. AU - Kwappenberg, K. M. C. AU - Hulst, J. M. AU - Drijfhout, J. W. PY - 2007 DA - 2007// TI - High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-06-3388 DO - 10.1158/0008-5472.CAN-06-3388 ID - Piersma2007 ER - TY - STD TI - Li J, Wang J, Chen R, Bai Y, Lu X. The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer. Oncotarget. 2017. http://www.oncotarget.com/abstract/14919. Accessed 29 Jun 2017. UR - http://www.oncotarget.com/abstract/14919 ID - ref35 ER - TY - JOUR AU - Lee, H. E. AU - Chae, S. W. AU - Lee, Y. J. AU - Kim, M. A. AU - Lee, H. S. AU - Lee, B. L. PY - 2008 DA - 2008// TI - Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer JO - Br J Cancer VL - 99 UR - https://doi.org/10.1038/sj.bjc.6604738 DO - 10.1038/sj.bjc.6604738 ID - Lee2008 ER - TY - JOUR AU - Mei, Z. AU - Liu, Y. AU - Liu, C. AU - Cui, A. AU - Liang, Z. AU - Wang, G. PY - 2014 DA - 2014// TI - Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis JO - Br J Cancer VL - 110 UR - https://doi.org/10.1038/bjc.2014.46 DO - 10.1038/bjc.2014.46 ID - Mei2014 ER - TY - JOUR AU - Hershkovitz, L. AU - Schachter, J. AU - Treves, A. J. AU - Besser, M. J. PY - 2010 DA - 2010// TI - Focus on adoptive T cell transfer trials in melanoma JO - Clin Dev Immunol VL - 2010 UR - https://doi.org/10.1155/2010/260267 DO - 10.1155/2010/260267 ID - Hershkovitz2010 ER - TY - JOUR AU - Rosenberg, S. A. AU - Packard, B. S. AU - Aebersold, P. M. AU - Solomon, D. AU - Topalian, S. L. AU - Toy, S. T. PY - 1988 DA - 1988// TI - Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma JO - N Engl J Med VL - 319 UR - https://doi.org/10.1056/NEJM198812223192527 DO - 10.1056/NEJM198812223192527 ID - Rosenberg1988 ER - TY - JOUR AU - Dudley, M. E. AU - Wunderlich, J. AU - Nishimura, M. I. AU - Yu, D. AU - Yang, J. C. AU - Topalian, S. L. PY - 2001 DA - 2001// TI - Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma JO - J Immunother VL - 24 UR - https://doi.org/10.1097/00002371-200107000-00012 DO - 10.1097/00002371-200107000-00012 ID - Dudley2001 ER - TY - JOUR AU - Dudley, M. E. PY - 2002 DA - 2002// TI - Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes JO - Science VL - 298 UR - https://doi.org/10.1126/science.1076514 DO - 10.1126/science.1076514 ID - Dudley2002 ER - TY - JOUR AU - Walter, E. A. AU - Greenberg, P. D. AU - Gilbert, M. J. AU - Finch, R. J. AU - Watanabe, K. S. AU - Thomas, E. D. PY - 1995 DA - 1995// TI - Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor JO - N Engl J Med VL - 333 UR - https://doi.org/10.1056/NEJM199510193331603 DO - 10.1056/NEJM199510193331603 ID - Walter1995 ER - TY - JOUR AU - Matloubian, M. AU - Concepcion, R. J. AU - Ahmed, R. PY - 1994 DA - 1994// TI - CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection JO - J Virol VL - 68 ID - Matloubian1994 ER - TY - JOUR AU - Dudley, M. E. AU - Wunderlich, J. R. AU - Yang, J. C. AU - Sherry, R. M. AU - Topalian, S. L. AU - Restifo, N. P. PY - 2005 DA - 2005// TI - adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.00.240 DO - 10.1200/JCO.2005.00.240 ID - Dudley2005 ER - TY - JOUR AU - Dudley, M. E. AU - Yang, J. C. AU - Sherry, R. AU - Hughes, M. S. AU - Royal, R. AU - Kammula, U. PY - 2008 DA - 2008// TI - Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2008.16.5449 DO - 10.1200/JCO.2008.16.5449 ID - Dudley2008 ER - TY - JOUR AU - Gattinoni, L. AU - Finkelstein, S. E. AU - Klebanoff, C. A. AU - Antony, P. A. AU - Palmer, D. C. AU - Spiess, P. J. PY - 2005 DA - 2005// TI - Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells JO - J Exp Med VL - 202 UR - https://doi.org/10.1084/jem.20050732 DO - 10.1084/jem.20050732 ID - Gattinoni2005 ER - TY - JOUR AU - Besser, M. J. AU - Shapira-Frommer, R. AU - Treves, A. J. AU - Zippel, D. AU - Itzhaki, O. AU - Hershkovitz, L. PY - 2010 DA - 2010// TI - Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients JO - Clin Cancer Res Off J Am Assoc Cancer Res VL - 16 UR - https://doi.org/10.1158/1078-0432.CCR-10-0041 DO - 10.1158/1078-0432.CCR-10-0041 ID - Besser2010 ER - TY - JOUR AU - Pilon-Thomas, S. AU - Kuhn, L. AU - Ellwanger, S. AU - Janssen, W. AU - Royster, E. AU - Marzban, S. PY - 2012 DA - 2012// TI - Efficacy of adoptive cell transfer of tumor-infiltrating lymphocytes after lymphopenia induction for metastatic melanoma JO - J Immunother VL - 35 UR - https://doi.org/10.1097/CJI.0b013e31826e8f5f DO - 10.1097/CJI.0b013e31826e8f5f ID - Pilon-Thomas2012 ER - TY - JOUR AU - Clay, T. M. AU - Custer, M. C. AU - Sachs, J. AU - Hwu, P. AU - Rosenberg, S. A. AU - Nishimura, M. I. PY - 1999 DA - 1999// TI - Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity JO - J Immunol VL - 163 ID - Clay1999 ER - TY - JOUR AU - Kunert, A. AU - Straetemans, T. AU - Govers, C. AU - Lamers, C. AU - Mathijssen, R. AU - Sleijfer, S. PY - 2013 DA - 2013// TI - TCR-engineered T cells meet new challenges to treat solid tumors: choice of antigen, T cell fitness, and sensitization of tumor milieu JO - Front Immunol VL - 4 UR - https://doi.org/10.3389/fimmu.2013.00363 DO - 10.3389/fimmu.2013.00363 ID - Kunert2013 ER - TY - JOUR AU - Robbins, P. F. AU - Dudley, M. E. AU - Wunderlich, J. AU - El-Gamil, M. AU - Li, Y. F. AU - Zhou, J. PY - 2004 DA - 2004// TI - Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy JO - J Immunol VL - 173 UR - https://doi.org/10.4049/jimmunol.173.12.7125 DO - 10.4049/jimmunol.173.12.7125 ID - Robbins2004 ER - TY - JOUR AU - Zhou, J. AU - Shen, X. AU - Huang, J. AU - Hodes, R. J. AU - Rosenberg, S. A. AU - Robbins, P. F. PY - 2005 DA - 2005// TI - Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy JO - J Immunol VL - 175 UR - https://doi.org/10.4049/jimmunol.175.10.7046 DO - 10.4049/jimmunol.175.10.7046 ID - Zhou2005 ER - TY - JOUR AU - Knowles, G. AU - O’Neil, B. W. AU - Campo, M. S. PY - 1996 DA - 1996// TI - Phenotypical characterization of lymphocytes infiltrating regressing papillomas JO - J Virol VL - 70 ID - Knowles1996 ER - TY - JOUR AU - Nicholls, P. K. AU - Moore, P. F. AU - Anderson, D. M. AU - Moore, R. A. AU - Parry, N. R. AU - Gough, G. W. PY - 2001 DA - 2001// TI - Regression of canine oral papillomas is associated with infiltration of CD4+ and CD8+ lymphocytes JO - Virology VL - 283 UR - https://doi.org/10.1006/viro.2000.0789 DO - 10.1006/viro.2000.0789 ID - Nicholls2001 ER - TY - JOUR AU - Pires, I. AU - Queiroga, F. L. AU - Alves, A. AU - Silva, F. AU - Lopes, C. PY - 2009 DA - 2009// TI - Decrease of E-cadherin expression in canine cutaneous histiocytoma appears to be related to its spontaneous regression JO - Anticancer Res VL - 29 ID - Pires2009 ER - TY - JOUR AU - Carvalho, M. I. AU - Pires, I. AU - Prada, J. AU - Queiroga, F. L. PY - 2014 DA - 2014// TI - A role for T-lymphocytes in human breast cancer and in canine mammary tumors JO - Biomed Res Int VL - 2014 UR - https://doi.org/10.1155/2014/130894 DO - 10.1155/2014/130894 ID - Carvalho2014 ER - TY - JOUR AU - Kim, J. -. H. AU - Yu, C. -. H. AU - Yhee, J. -. Y. AU - Im, K. -. S. AU - Sur, J. -. H. PY - 2010 DA - 2010// TI - Lymphocyte infiltration, expression of interleukin (IL)-1, IL-6 and expression of mutated breast cancer susceptibility gene-1 correlate with malignancy of canine mammary tumours JO - J Comp Pathol VL - 142 UR - https://doi.org/10.1016/j.jcpa.2009.10.023 DO - 10.1016/j.jcpa.2009.10.023 ID - Kim2010 ER - TY - STD TI - Estrela-Lima A, Araujo MS, Costa-Neto JM, Teixeira-Carvalho A, Barrouin-Melo SM, Cardoso SV, et al. Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates. BMC Cancer. 2010;10. http://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-10-256. Accessed 29 Jun 2017. UR - http://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-10-256 ID - ref58 ER - TY - JOUR AU - Carvalho, M. I. AU - Pires, I. AU - Prada, J. AU - Queiroga, F. L. PY - 2011 DA - 2011// TI - T-lymphocytic infiltrate in canine mammary tumours: clinic and prognostic implications JO - Vivo Athens Greece VL - 25 ID - Carvalho2011 ER - TY - JOUR AU - Saeki, K. AU - Endo, Y. AU - Uchida, K. AU - Nishimura, R. AU - Sasaki, N. AU - Nakagawa, T. PY - 2012 DA - 2012// TI - Significance of tumor-infiltrating immune cells in spontaneous canine mammary gland tumor: 140 cases JO - J Vet Med Sci VL - 74 UR - https://doi.org/10.1292/jvms.11-0118 DO - 10.1292/jvms.11-0118 ID - Saeki2012 ER - TY - JOUR AU - Kim, S. T. AU - Jeong, H. AU - Woo, O. H. AU - Seo, J. H. AU - Kim, A. AU - Lee, E. S. PY - 2013 DA - 2013// TI - Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer JO - Am J Clin Oncol VL - 36 UR - https://doi.org/10.1097/COC.0b013e3182467d90 DO - 10.1097/COC.0b013e3182467d90 ID - Kim2013 ER - TY - JOUR AU - Mucha, J. AU - Rybicka, A. AU - Dolka, I. AU - Szymańska, J. AU - Manuali, E. AU - Parzeniecka-Jaworska, M. PY - 2016 DA - 2016// TI - Immunosuppression in dogs during mammary cancer development JO - Vet Pathol VL - 53 UR - https://doi.org/10.1177/0300985816634808 DO - 10.1177/0300985816634808 ID - Mucha2016 ER - TY - JOUR AU - Tominaga, M. AU - Horiuchi, Y. AU - Ichikawa, M. AU - Yamashita, M. AU - Okano, K. AU - Jikumaru, Y. PY - 2010 DA - 2010// TI - Flow cytometric analysis of peripheral blood and tumor-infiltrating regulatory T cells in dogs with oral malignant melanoma JO - J Vet Diagn Investig VL - 22 UR - https://doi.org/10.1177/104063871002200317 DO - 10.1177/104063871002200317 ID - Tominaga2010 ER - TY - JOUR AU - O’Connor, C. M. AU - Sheppard, S. AU - Hartline, C. A. AU - Huls, H. AU - Johnson, M. AU - Palla, S. L. PY - 2012 DA - 2012// TI - Adoptive T-cell therapy improves treatment of canine non-Hodgkin lymphoma post chemotherapy JO - Sci Rep VL - 2 UR - https://doi.org/10.1038/srep00249 DO - 10.1038/srep00249 ID - O’Connor2012 ER - TY - JOUR AU - Mata, M. AU - Vera, J. F. AU - Gerken, C. AU - Rooney, C. M. AU - Miller, T. AU - Pfent, C. PY - 2014 DA - 2014// TI - Toward immunotherapy with redirected T cells in a large animal model: ex vivo activation, expansion, and genetic modification of canine T cells JO - J Immunother VL - 37 UR - https://doi.org/10.1097/CJI.0000000000000052 DO - 10.1097/CJI.0000000000000052 ID - Mata2014 ER - TY - JOUR AU - Yee, C. AU - Thompson, J. A. AU - Byrd, D. AU - Riddell, S. R. AU - Roche, P. AU - Celis, E. PY - 2002 DA - 2002// TI - Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells JO - Proc Natl Acad Sci USA VL - 99 UR - https://doi.org/10.1073/pnas.242600099 DO - 10.1073/pnas.242600099 ID - Yee2002 ER - TY - JOUR AU - Butler, M. O. AU - Friedlander, P. AU - Milstein, M. I. AU - Mooney, M. M. AU - Metzler, G. AU - Murray, A. P. PY - 2011 DA - 2011// TI - Establishment of antitumor memory in humans using in vitro-educated CD8+ T cells JO - Sci Transl Med VL - 3 UR - https://doi.org/10.1126/scitranslmed.3002207 DO - 10.1126/scitranslmed.3002207 ID - Butler2011 ER - TY - JOUR AU - Gabert, J. AU - Langlet, C. AU - Zamoyska, R. AU - Parnes, J. R. AU - Schmitt-Verhulst, A. M. AU - Malissen, B. PY - 1987 DA - 1987// TI - Reconstitution of MHC class I specificity by transfer of the T cell receptor and Lyt-2 genes JO - Cell VL - 50 UR - https://doi.org/10.1016/0092-8674(87)90027-4 DO - 10.1016/0092-8674(87)90027-4 ID - Gabert1987 ER - TY - JOUR AU - DembiĆ, Z. AU - Haas, W. AU - Weiss, S. AU - McCubrey, J. AU - Kiefer, H. AU - Boehmer, H. PY - 1986 DA - 1986// TI - Transfer of specificity by murine α and β T-cell receptor genes JO - Nature VL - 320 UR - https://doi.org/10.1038/320232a0 DO - 10.1038/320232a0 ID - DembiĆ1986 ER - TY - JOUR AU - Engels, B. AU - Noessner, E. AU - Frankenberger, B. AU - Blankenstein, T. AU - Schendel, D. J. AU - Uckert, W. PY - 2005 DA - 2005// TI - Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes JO - Hum Gene Ther VL - 16 UR - https://doi.org/10.1089/hum.2005.16.799 DO - 10.1089/hum.2005.16.799 ID - Engels2005 ER - TY - JOUR AU - Xue, S. -. A. AU - Gao, L. AU - Hart, D. AU - Gillmore, R. AU - Qasim, W. AU - Thrasher, A. PY - 2005 DA - 2005// TI - Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells JO - Blood VL - 106 UR - https://doi.org/10.1182/blood-2005-01-0146 DO - 10.1182/blood-2005-01-0146 ID - Xue2005 ER - TY - JOUR AU - Morgan, R. A. AU - Dudley, M. E. AU - Wunderlich, J. R. AU - Hughes, M. S. AU - Yang, J. C. AU - Sherry, R. M. PY - 2006 DA - 2006// TI - Cancer regression in patients after transfer of genetically engineered lymphocytes JO - Science VL - 314 UR - https://doi.org/10.1126/science.1129003 DO - 10.1126/science.1129003 ID - Morgan2006 ER - TY - JOUR AU - Rapoport, A. P. AU - Stadtmauer, E. A. AU - Binder-Scholl, G. K. AU - Goloubeva, O. AU - Vogl, D. T. AU - Lacey, S. F. PY - 2015 DA - 2015// TI - NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma JO - Nat Med VL - 21 UR - https://doi.org/10.1038/nm.3910 DO - 10.1038/nm.3910 ID - Rapoport2015 ER - TY - JOUR AU - Thomas, S. AU - Stauss, H. J. AU - Morris, E. C. PY - 2010 DA - 2010// TI - Molecular immunology lessons from therapeutic T-cell receptor gene transfer JO - Immunology VL - 129 UR - https://doi.org/10.1111/j.1365-2567.2009.03227.x DO - 10.1111/j.1365-2567.2009.03227.x ID - Thomas2010 ER - TY - JOUR AU - Sommermeyer, D. AU - Neudorfer, J. AU - Weinhold, M. AU - Leisegang, M. AU - Engels, B. AU - Noessner, E. PY - 2006 DA - 2006// TI - Designer T cells by T cell receptor replacement JO - Eur J Immunol VL - 36 UR - https://doi.org/10.1002/eji.200636539 DO - 10.1002/eji.200636539 ID - Sommermeyer2006 ER - TY - JOUR AU - Sarukhan, A. AU - Garcia, C. AU - Lanoue, A. AU - Boehmer, H. PY - 1998 DA - 1998// TI - Allelic inclusion of T cell receptor alpha genes poses an autoimmune hazard due to low-level expression of autospecific receptors JO - Immunity VL - 8 UR - https://doi.org/10.1016/S1074-7613(00)80561-0 DO - 10.1016/S1074-7613(00)80561-0 ID - Sarukhan1998 ER - TY - JOUR AU - Gladow, M. AU - Uckert, W. AU - Blankenstein, T. PY - 2004 DA - 2004// TI - Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors JO - Eur J Immunol VL - 34 UR - https://doi.org/10.1002/eji.200425041 DO - 10.1002/eji.200425041 ID - Gladow2004 ER - TY - JOUR AU - Bendle, G. M. AU - Linnemann, C. AU - Hooijkaas, A. I. AU - Bies, L. AU - Witte, M. A. AU - Jorritsma, A. PY - 2010 DA - 2010// TI - Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy JO - Nat Med VL - 16 UR - https://doi.org/10.1038/nm.2128 DO - 10.1038/nm.2128 ID - Bendle2010 ER - TY - JOUR AU - Linette, G. P. AU - Stadtmauer, E. A. AU - Maus, M. V. AU - Rapoport, A. P. AU - Levine, B. L. AU - Emery, L. PY - 2013 DA - 2013// TI - Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma JO - Blood VL - 122 UR - https://doi.org/10.1182/blood-2013-03-490565 DO - 10.1182/blood-2013-03-490565 ID - Linette2013 ER - TY - JOUR AU - Barth, S. M. AU - Schreitmüller, C. M. AU - Proehl, F. AU - Oehl, K. AU - Lumpp, L. M. AU - Kowalewski, D. J. PY - 2016 DA - 2016// TI - Characterization of the Canine MHC Class I DLA-88*50101 Peptide binding motif as a prerequisite for canine T cell immunotherapy JO - PLoS ONE VL - 11 UR - https://doi.org/10.1371/journal.pone.0167017 DO - 10.1371/journal.pone.0167017 ID - Barth2016 ER - TY - JOUR AU - Garrido, F. AU - Ruiz-Cabello, F. AU - Cabrera, T. AU - Pérez-Villar, J. J. AU - López-Botet, M. AU - Duggan-Keen, M. PY - 1997 DA - 1997// TI - Implications for immunosurveillance of altered HLA class I phenotypes in human tumours JO - Immunol Today VL - 18 UR - https://doi.org/10.1016/S0167-5699(96)10075-X DO - 10.1016/S0167-5699(96)10075-X ID - Garrido1997 ER - TY - JOUR AU - Gross, G. AU - Waks, T. AU - Eshhar, Z. PY - 1989 DA - 1989// TI - Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity JO - Proc Natl Acad Sci USA VL - 86 UR - https://doi.org/10.1073/pnas.86.24.10024 DO - 10.1073/pnas.86.24.10024 ID - Gross1989 ER - TY - JOUR AU - Jena, B. AU - Dotti, G. AU - Cooper, L. J. N. PY - 2010 DA - 2010// TI - Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor JO - Blood VL - 116 UR - https://doi.org/10.1182/blood-2010-01-043737 DO - 10.1182/blood-2010-01-043737 ID - Jena2010 ER - TY - JOUR AU - Gilham, D. E. AU - Debets, R. AU - Pule, M. AU - Hawkins, R. E. AU - Abken, H. PY - 2012 DA - 2012// TI - CAR–T cells and solid tumors: tuning T cells to challenge an inveterate foe JO - Trends Mol Med VL - 18 UR - https://doi.org/10.1016/j.molmed.2012.04.009 DO - 10.1016/j.molmed.2012.04.009 ID - Gilham2012 ER - TY - JOUR AU - Berry, L. J. AU - Moeller, M. AU - Darcy, P. K. PY - 2009 DA - 2009// TI - Adoptive immunotherapy for cancer: the next generation of gene-engineered immune cells JO - Tissue Antigens VL - 74 UR - https://doi.org/10.1111/j.1399-0039.2009.01336.x DO - 10.1111/j.1399-0039.2009.01336.x ID - Berry2009 ER - TY - JOUR AU - Dai, H. AU - Wang, Y. AU - Lu, X. AU - Han, W. PY - 2016 DA - 2016// TI - Chimeric antigen receptors modified t-cells for cancer therapy JO - J Natl Cancer Inst UR - https://doi.org/10.1093/jnci/djv439 DO - 10.1093/jnci/djv439 ID - Dai2016 ER - TY - JOUR AU - Hombach, A. A. AU - Abken, H. PY - 2011 DA - 2011// TI - Costimulation by chimeric antigen receptors revisited the T cell antitumor response benefits from combined CD28-OX40 signalling JO - Int J Cancer VL - 129 UR - https://doi.org/10.1002/ijc.25960 DO - 10.1002/ijc.25960 ID - Hombach2011 ER - TY - JOUR AU - Bridgeman, J. S. AU - Hawkins, R. E. AU - Hombach, A. A. AU - Abken, H. AU - Gilham, D. E. PY - 2010 DA - 2010// TI - Building better chimeric antigen receptors for adoptive T cell therapy JO - Curr Gene Ther VL - 10 UR - https://doi.org/10.2174/156652310791111001 DO - 10.2174/156652310791111001 ID - Bridgeman2010 ER - TY - JOUR AU - Grupp, S. A. AU - Kalos, M. AU - Barrett, D. AU - Aplenc, R. AU - Porter, D. L. AU - Rheingold, S. R. PY - 2013 DA - 2013// TI - Chimeric antigen receptor-modified T cells for acute lymphoid leukemia JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMoa1215134 DO - 10.1056/NEJMoa1215134 ID - Grupp2013 ER - TY - JOUR AU - Louis, C. U. AU - Savoldo, B. AU - Dotti, G. AU - Pule, M. AU - Yvon, E. AU - Myers, G. D. PY - 2011 DA - 2011// TI - Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma JO - Blood VL - 118 UR - https://doi.org/10.1182/blood-2011-05-354449 DO - 10.1182/blood-2011-05-354449 ID - Louis2011 ER - TY - JOUR AU - Kershaw, M. H. AU - Westwood, J. A. AU - Parker, L. L. AU - Wang, G. AU - Eshhar, Z. AU - Mavroukakis, S. A. PY - 2006 DA - 2006// TI - A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-06-1183 DO - 10.1158/1078-0432.CCR-06-1183 ID - Kershaw2006 ER - TY - JOUR AU - Lamers, C. H. J. AU - Sleijfer, S. AU - Vulto, A. G. AU - Kruit, W. H. J. AU - Kliffen, M. AU - Debets, R. PY - 2006 DA - 2006// TI - Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2006.05.9964 DO - 10.1200/JCO.2006.05.9964 ID - Lamers2006 ER - TY - JOUR AU - Lamers, C. H. AU - Sleijfer, S. AU - Steenbergen, S. AU - Elzakker, P. AU - Krimpen, B. AU - Groot, C. PY - 2013 DA - 2013// TI - Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity JO - Mol Ther J Am Soc Gene Ther VL - 21 UR - https://doi.org/10.1038/mt.2013.17 DO - 10.1038/mt.2013.17 ID - Lamers2013 ER - TY - JOUR AU - Zhang, E. AU - Xu, H. PY - 2017 DA - 2017// TI - A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy JO - J Hematol Oncol VL - 10 UR - https://doi.org/10.1186/s13045-016-0379-6 DO - 10.1186/s13045-016-0379-6 ID - Zhang2017 ER - TY - JOUR AU - Panjwani, M. K. AU - Smith, J. B. AU - Schutsky, K. AU - Gnanandarajah, J. AU - O’Connor, C. M. AU - Powell, D. J. PY - 2016 DA - 2016// TI - Feasibility and Safety of RNA-transfected CD20-specific chimeric antigen receptor T cells in dogs with spontaneous B cell lymphoma JO - Mol Ther VL - 24 UR - https://doi.org/10.1038/mt.2016.146 DO - 10.1038/mt.2016.146 ID - Panjwani2016 ER - TY - JOUR AU - Rosenberg, S. A. AU - Lotze, M. T. PY - 1986 DA - 1986// TI - Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes JO - Annu Rev Immunol VL - 4 UR - https://doi.org/10.1146/annurev.iy.04.040186.003341 DO - 10.1146/annurev.iy.04.040186.003341 ID - Rosenberg1986 ER - TY - JOUR AU - Hoshino, Y. AU - Takagi, S. AU - Osaki, T. AU - Okumura, M. AU - Fujinaga, T. PY - 2008 DA - 2008// TI - Phenotypic analysis and effects of sequential administration of activated canine lymphocytes on healthy beagles JO - J Vet Med Sci VL - 70 UR - https://doi.org/10.1292/jvms.70.581 DO - 10.1292/jvms.70.581 ID - Hoshino2008 ER - TY - JOUR AU - Helfand, S. C. AU - Soergel, S. A. AU - Modiano, J. F. AU - Hank, J. A. AU - Sondel, P. M. PY - 1994 DA - 1994// TI - Induction of lymphokine-activated killer (LAK) activity in canine lymphocytes with low dose human recombinant interleukin-2 in vitro JO - Cancer Biother VL - 9 UR - https://doi.org/10.1089/cbr.1994.9.237 DO - 10.1089/cbr.1994.9.237 ID - Helfand1994 ER - TY - JOUR AU - Itoh, H. AU - Kakuta, T. AU - Kudo, T. AU - Sakonju, I. AU - Hohdatsu, T. AU - Ebina, T. PY - 2003 DA - 2003// TI - Bulk cultures of canine peripheral blood lymphocytes with solid phase anti-CD3 antibody and recombinant interleukin-2 for use in immunotherapy JO - J Vet Med Sci VL - 65 UR - https://doi.org/10.1292/jvms.65.329 DO - 10.1292/jvms.65.329 ID - Itoh2003 ER - TY - JOUR AU - Mie, K. AU - Shimada, T. AU - Akiyoshi, H. AU - Hayashi, A. AU - Ohashi, F. PY - 2016 DA - 2016// TI - Change in peripheral blood lymphocyte count in dogs following adoptive immunotherapy using lymphokine-activated T killer cells combined with palliative tumor resection JO - Vet Immunol Immunopathol VL - 177 UR - https://doi.org/10.1016/j.vetimm.2016.06.007 DO - 10.1016/j.vetimm.2016.06.007 ID - Mie2016 ER - TY - JOUR AU - Cox, D. B. T. AU - Platt, R. J. AU - Zhang, F. PY - 2015 DA - 2015// TI - Therapeutic genome editing: prospects and challenges JO - Nat Med VL - 21 UR - https://doi.org/10.1038/nm.3793 DO - 10.1038/nm.3793 ID - Cox2015 ER - TY - JOUR AU - Urnov, F. D. AU - Rebar, E. J. AU - Holmes, M. C. AU - Zhang, H. S. AU - Gregory, P. D. PY - 2010 DA - 2010// TI - Genome editing with engineered zinc finger nucleases JO - Nat Rev Genet VL - 11 UR - https://doi.org/10.1038/nrg2842 DO - 10.1038/nrg2842 ID - Urnov2010 ER - TY - JOUR AU - Nemudryi, A. A. AU - Valetdinova, K. R. AU - Medvedev, S. P. AU - Zakian, S. M. PY - 2014 DA - 2014// TI - TALEN and CRISPR/Cas genome editing systems: tools of discovery JO - Acta Nat VL - 6 ID - Nemudryi2014 ER - TY - JOUR AU - Joung, J. K. AU - Sander, J. D. PY - 2013 DA - 2013// TI - TALENs: a widely applicable technology for targeted genome editing JO - Nat Rev Mol Cell Biol VL - 14 UR - https://doi.org/10.1038/nrm3486 DO - 10.1038/nrm3486 ID - Joung2013 ER - TY - JOUR AU - Hsu, P. D. AU - Lander, E. S. AU - Zhang, F. PY - 2014 DA - 2014// TI - Development and applications of CRISPR-Cas9 for genome engineering JO - Cell VL - 157 UR - https://doi.org/10.1016/j.cell.2014.05.010 DO - 10.1016/j.cell.2014.05.010 ID - Hsu2014 ER - TY - JOUR AU - Gaj, T. AU - Gersbach, C. A. AU - Barbas, C. F. PY - 2013 DA - 2013// TI - ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering JO - Trends Biotechnol VL - 31 UR - https://doi.org/10.1016/j.tibtech.2013.04.004 DO - 10.1016/j.tibtech.2013.04.004 ID - Gaj2013 ER - TY - JOUR AU - Li, H. AU - Haurigot, V. AU - Doyon, Y. AU - Li, T. AU - Wong, S. Y. AU - Bhagwat, A. S. PY - 2011 DA - 2011// TI - In vivo genome editing restores haemostasis in a mouse model of haemophilia JO - Nature VL - 475 UR - https://doi.org/10.1038/nature10177 DO - 10.1038/nature10177 ID - Li2011 ER - TY - JOUR AU - Yin, H. AU - Xue, W. AU - Chen, S. AU - Bogorad, R. L. AU - Benedetti, E. AU - Grompe, M. PY - 2014 DA - 2014// TI - Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype JO - Nat Biotechnol VL - 32 UR - https://doi.org/10.1038/nbt.2884 DO - 10.1038/nbt.2884 ID - Yin2014 ER - TY - JOUR AU - Lin, S. -. R. AU - Yang, H. -. C. AU - Kuo, Y. -. T. AU - Liu, C. -. J. AU - Yang, T. -. Y. AU - Sung, K. -. C. PY - 2014 DA - 2014// TI - The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo JO - Mol Ther Nucleic Acids VL - 3 UR - https://doi.org/10.1038/mtna.2014.38 DO - 10.1038/mtna.2014.38 ID - Lin2014 ER - TY - JOUR AU - Ousterout, D. G. AU - Perez-Pinera, P. AU - Thakore, P. I. AU - Kabadi, A. M. AU - Brown, M. T. AU - Qin, X. PY - 2013 DA - 2013// TI - Reading frame correction by targeted genome editing restores dystrophin expression in cells from duchenne muscular dystrophy patients JO - Mol Ther VL - 21 UR - https://doi.org/10.1038/mt.2013.111 DO - 10.1038/mt.2013.111 ID - Ousterout2013 ER - TY - JOUR AU - Reardon, S. PY - 2015 DA - 2015// TI - Leukaemia success heralds wave of gene-editing therapies JO - Nature VL - 527 UR - https://doi.org/10.1038/nature.2015.18737 DO - 10.1038/nature.2015.18737 ID - Reardon2015 ER - TY - JOUR AU - Qasim, W. AU - Zhan, H. AU - Samarasinghe, S. AU - Adams, S. AU - Amrolia, P. AU - Stafford, S. PY - 2017 DA - 2017// TI - Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells JO - Sci Transl Med VL - 9 UR - https://doi.org/10.1126/scitranslmed.aaj2013 DO - 10.1126/scitranslmed.aaj2013 ID - Qasim2017 ER - TY - JOUR AU - Torikai, H. AU - Reik, A. AU - Liu, P. -. Q. AU - Zhou, Y. AU - Zhang, L. AU - Maiti, S. PY - 2012 DA - 2012// TI - A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR JO - Blood VL - 119 UR - https://doi.org/10.1182/blood-2012-01-405365 DO - 10.1182/blood-2012-01-405365 ID - Torikai2012 ER - TY - JOUR AU - Provasi, E. AU - Genovese, P. AU - Lombardo, A. AU - Magnani, Z. AU - Liu, P. -. Q. AU - Reik, A. PY - 2012 DA - 2012// TI - Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer JO - Nat Med VL - 18 UR - https://doi.org/10.1038/nm.2700 DO - 10.1038/nm.2700 ID - Provasi2012 ER - TY - JOUR AU - Peng, R. AU - Lin, G. AU - Li, J. PY - 2016 DA - 2016// TI - Potential pitfalls of CRISPR/Cas9-mediated genome editing JO - FEBS J VL - 283 UR - https://doi.org/10.1111/febs.13586 DO - 10.1111/febs.13586 ID - Peng2016 ER - TY - JOUR AU - Zou, Q. AU - Wang, X. AU - Liu, Y. AU - Ouyang, Z. AU - Long, H. AU - Wei, S. PY - 2015 DA - 2015// TI - Generation of gene-target dogs using CRISPR/Cas9 system JO - J Mol Cell Biol VL - 7 UR - https://doi.org/10.1093/jmcb/mjv061 DO - 10.1093/jmcb/mjv061 ID - Zou2015 ER -